MedPath

Assessment of Right Ventricular Function in Advanced Heart Failure

Completed
Conditions
Dilated Cardiomyopathy
Heart Failure
Registration Number
NCT03893760
Lead Sponsor
ITAB - Institute for Advanced Biomedical Technologies
Brief Summary

We examined the feasibility and reliability of a combined echocardiographic and right heart catheterization (RHC) approach for right ventriculo/arterial (R-V/A) coupling assessment in HF patients with dilated cardiomyopathy (D-CMP).

Detailed Description

This is a single center, retrospective cross-sectional study. In 2016-17, for 6 months, we evaluated for eligibility 81 consecutive D-CMP patients afferent to "Niguarda Great Metropolitan Hospital" for RHC and echocardiography. All participants underwent the exams in the context of heart-transplant or advanced HF evaluation. Inclusion criteria were: 18 years old, given informed consent, D-CMP, New York Heart Association (NYHA) functional class II or III and reduced EF (≤ 35%). On the contrary, exclusion criteria were: missing the inclusion criteria and refused informed consent. The final sample consisted of 68 study participants (mean age 64±7 years, 82 % male).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • 18 years old
  • Given informed consent
  • D-CMP
  • New York Heart Association (NYHA) functional class II or III
  • Reduced EF (≤ 35%)
Exclusion Criteria
  • Missing the inclusion criteria
  • Refused informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Participants with altered Right ventriculo/arterial (R-V/A) coupling over PAPm and Pulmonary Hypertension typesup to 24 weeks

Significant correlations and augmentation over PAPm and Pulmonay Hypertension

Secondary Outcome Measures
NameTimeMethod
Rate of agreement in Right ventriculo/arterial (R-V/A) coupling assessmentup to 24 weeks

Two independent physicians, both experts in echocardiography, independently re-examined 40 studies, randomly selected from all the acquired echocardiographic images. In order to test the R-V/A coupling interobserver agreement

Trial Locations

Locations (2)

University "G. d'Annunzio"

🇮🇹

Chieti, Italy

Niguarda Great Metropolitan Hospital

🇮🇹

Milan, Italy

University "G. d'Annunzio"
🇮🇹Chieti, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.